Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
Blood Adv. 2023 Dec 26;7(24):7494-7500. doi: 10.1182/bloodadvances.2023010943.
Blood Adv. 2023.
PMID: 37903324
Free PMC article.
Clinical Trial.
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.
Zuckerman T, Ram R, Akria L, Koren-Michowitz M, Hoffman R, Henig I, Lavi N, Ofran Y, Horowitz NA, Nudelman O, Tavor S, Yeganeh S, Gengrinovitch S, Flaishon L, Tessler S, Ben Yakar R, Rowe JM.
Zuckerman T, et al. Among authors: ben yakar r.
Blood Adv. 2019 Nov 26;3(22):3740-3749. doi: 10.1182/bloodadvances.2019000468.
Blood Adv. 2019.
PMID: 31770437
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy outcomes in the treatment of older or medically unfit patients with acute myeloid leukaemia: A systematic review and meta-analysis.
Stone A, Zukerman T, Flaishon L, Yakar RB, Rowe JM.
Stone A, et al. Among authors: yakar rb.
Leuk Res. 2019 Jul;82:36-42. doi: 10.1016/j.leukres.2019.05.007. Epub 2019 May 21.
Leuk Res. 2019.
PMID: 31152922
Free article.
Item in Clipboard
Cite
Cite